LEUKOCARE's Corporate Minority Round

LEUKOCARE raised a round of funding on February 02, 2017. Investors include Rentschler Biotechnologie.

LEUKOCARE provides a next-generation formulation technology platform for the protection of biological compounds to allow the development of better products. The proprietary SPS technologies are provid…

Articles about LEUKOCARE's Corporate Minority Round: